BioVentrix
SAN RAMON, CA · Medical, Other · 20 employees
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.
Funding history
- Series seed — $705K — Apr 2026
- Funding Round — $6.7M — Nov 2025
- Series seed — $3.6M — Jul 2025
- Series pre-seed — $125K — Oct 2024
- Series seed — $3.0M — Aug 2024
Recent signals
- Apr 24, 2026: Raised $705K in Series seed
- Nov 04, 2025: Raised $6.7M
- Jul 08, 2025: Raised $3.6M in Series seed
- Oct 16, 2024: Raised $125K in Series pre-seed
- Aug 29, 2024: Raised $3.0M in Series seed
- Mar 29, 2024: Raised $2.4M in Series seed
- Apr 13, 2023: Raised $48.5M in Series series a
- Apr 04, 2023: Raised $12.7M
See plans & pricing → Track BioVentrix’s funding, hiring, and signals — with verified contacts — on Fundz.